FDA Inspection 1039237 — Synteract, Inc.
The FDA completed an inspection of Synteract, Inc. on January 12, 2018 in Carlsbad, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 12, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Carlsbad, CA (United States)
Additional Details
Sponsor, Contract Research Organization